Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kavanaugh

Showing results (31-40 of 158) with videos related to

Pageof 16
Sort By:
The Journal of Extra-Corporeal Technology|February 6, 1998
Perfusion services national process improvement benchmarkingJ B Riley, T A Kavanaugh
Plos Genetics|January 3, 2009
Non-coding RNA prediction and verification in Saccharomyces cerevisiaeLaura A Kavanaugh, Fred S Dietrich
Clinical and Experimental Rheumatology|November 24, 2004
Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for "near remission" of DAS or single measuresT Pincus, T Sokka, A Kavanaugh
The Journal of Rheumatology|November 18, 1998
Inhibitors of tumor necrosis factor in rheumatoid arthritis: Will that dog hunt?A Kavanaugh, S Cohen, J Cush
The Journal of Rheumatology|April 1, 1995
Central nervous system angiopathy associated with cocaine abuseK Martin, T Rogers, A Kavanaugh
Clinical Pediatrics|October 1, 1995
Oximetry and capnography during sedation for transesophageal echocardiographyJ D Tobias, A Kavanaugh-McHugh
Rheumatology (Oxford, England)|April 23, 2004
Disease measures in evaluating the effect of anti-TNF therapy and predicting clinical outcomeZ Tutuncu, C Bansal, A Kavanaugh
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapiesT Pincus, A Kavanaugh, T Sokka
Clinical and Experimental Rheumatology|November 24, 2004
Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard careT Pincus, T Sokka, A Kavanaugh
Clinical and Experimental Rheumatology|November 24, 2004
Internet-based monitoring of patients with rheumatoid arthritisS J Lee, L Lenert, A Kavanaugh
Pageof 16

Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Extra-Corporeal Technology|February 6, 1998
Perfusion services national process improvement benchmarkingJ B Riley, T A Kavanaugh
Plos Genetics|January 3, 2009
Non-coding RNA prediction and verification in Saccharomyces cerevisiaeLaura A Kavanaugh, Fred S Dietrich
Clinical and Experimental Rheumatology|November 24, 2004
Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for "near remission" of DAS or single measuresT Pincus, T Sokka, A Kavanaugh
The Journal of Rheumatology|November 18, 1998
Inhibitors of tumor necrosis factor in rheumatoid arthritis: Will that dog hunt?A Kavanaugh, S Cohen, J Cush
The Journal of Rheumatology|April 1, 1995
Central nervous system angiopathy associated with cocaine abuseK Martin, T Rogers, A Kavanaugh
Clinical Pediatrics|October 1, 1995
Oximetry and capnography during sedation for transesophageal echocardiographyJ D Tobias, A Kavanaugh-McHugh
Rheumatology (Oxford, England)|April 23, 2004
Disease measures in evaluating the effect of anti-TNF therapy and predicting clinical outcomeZ Tutuncu, C Bansal, A Kavanaugh
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapiesT Pincus, A Kavanaugh, T Sokka
Clinical and Experimental Rheumatology|November 24, 2004
Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard careT Pincus, T Sokka, A Kavanaugh
Clinical and Experimental Rheumatology|November 24, 2004
Internet-based monitoring of patients with rheumatoid arthritisS J Lee, L Lenert, A Kavanaugh
Pageof 16